- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/635 - Compounds containing para-N-benzene- sulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonohydrazide having a heterocyclic ring, e.g. sulfadiazine
Patent holdings for IPC class A61K 31/635
Total number of patents in this class: 1159
10-year publication summary
|
102
|
106
|
97
|
117
|
96
|
128
|
158
|
115
|
126
|
8
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| scPharmaceuticals Inc. | 34 |
20 |
| Novartis AG | 11254 |
17 |
| Mayo Foundation for Medical Education and Research | 3115 |
17 |
| Dana-Farber Cancer Institute, Inc. | 2535 |
15 |
| The Johns Hopkins University | 5533 |
14 |
| Board of Regents, The University of Texas System | 5619 |
12 |
| Dogwood Therapeutics, Inc. | 13 |
12 |
| Ascentage Pharma (Suzhou) Co., Ltd. | 164 |
11 |
| The Regents of the University of California | 19517 |
10 |
| Boehringer Ingelheim Vetmedica GmbH | 1289 |
10 |
| Merck Sharp & Dohme LLC | 3751 |
10 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3356 |
9 |
| Rigel Pharmaceuticals, Inc. | 586 |
9 |
| Genentech, Inc. | 3869 |
8 |
| Celgene Corporation | 1468 |
8 |
| Esteve Pharmaceuticals, S.A. | 218 |
8 |
| Ascentage Pharma Group Corp Limited | 129 |
8 |
| AstraZeneca AB | 2958 |
7 |
| Abbvie Inc. | 1782 |
7 |
| Centre National de La Recherche Scientifique | 10102 |
6 |
| Other owners | 941 |